The companies Eikon Therapeutics, Sionna Therapeutics, and Abcuro bagged the biggest biotech funding rounds overall in ...

Find out how the virtual biotech company Libra Therapeutics leveraged data to accelerate drug development for ...

As we observe Rare Disease Day today, let us take a look at seven drugs poised to be approved to address rare diseases in ...

Eli Lilly kicks off 2025 with key licensing deals and M&A, boosting its position across therapeutic areas amid rising drug ...

Many respiratory diseases have a huge effect on the lungs and other parts of the respiratory system and can be caused by various factors, including infection, exposure to air pollution, or smoking ...

When David Bennet received a new heart in January 2022, there was something very unusual about the organ being transplanted into his body – instead of coming from a human donor, it was actually a ...

What are T cell engagers? This class of drugs has shot to fame in recent years because of their ability to harness the immune system. T cell engagers are antibodies that are engineered to recognize ...

When Vertex Pharmaceuticals announced last month that its pain pill had received approval from the U.S. Food and Drug Administration (FDA), it marked a major breakthrough in the hunt for new ...

The biotech industry is under legal fire. While 2024 has been a year of resilience in terms of performance for the industry, there’s been a sharp increase in the number of class action lawsuits ...